Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2023 Publisher: Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216, Ingelheim am Rhein, Germany
Striverdi Respimat 2.5 microgram, inhalation solution.
| Pharmaceutical Form |
|---|
|
Inhalation solution. Clear, colourless, inhalation solution. |
The delivered dose is 2.5 microgram Olodaterol (as hydrochloride) per actuation.
The delivered dose is the dose which is available for the patient after passing the mouthpiece.
Excipient with known effect: This medicine contains 0.0011 mg benzalkonium chloride in each actuation.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Olodaterol |
Olodaterol has a high affinity and high selectivity to the human beta2-adrenoceptor. The compound exerts its pharmacological effects by binding and activation of beta2-adrenoceptors after topical administration by inhalation. Activation of these receptors in the airways results in a stimulation of intracellular adenyl cyclase, an enzyme that mediates the synthesis of cyclic-3',5' adenosine monophosphate (cAMP). Elevated levels of cAMP induce bronchodilation by relaxation of airway smooth muscle cells. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
Type and material of the container in contact with the medicinal product:
Solution filled into a polyethylene/polypropylene cartridge with a polypropylene cap with integrated silicone sealing ring. The cartridge is enclosed within an aluminium cylinder.
Each cartridge contains 4 ml inhalation solution.
Pack sizes and devices supplied:
Single pack: 1 Respimat re-usable inhaler and 1 cartridge, providing 60 actuations (puffs) (30 medicinal doses).
Triple pack: 1 Respimat re-usable inhaler and 3 cartridges, providing 60 actuations (puffs) (30 medicinal doses) each.
Single refill pack: 1 cartridge, providing 60 actuations (puffs) (30 medicinal doses).
Triple refill pack: 3 cartridges, providing 60 actuations (puffs) (30 medicinal doses) each.
Not all pack sizes may be marketed.
Boehringer Ingelheim International GmbH, Binger Strasse 173, D-55216, Ingelheim am Rhein, Germany
PL 14598/0093
07/06/2018
| Drug | Countries | |
|---|---|---|
| STRIVERDI RESPIMAT | Austria, Brazil, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom, United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
